30Ventures is an early-stage healthcare and biotechnology venture capital firm focused on high-potential, capital-efficient companies raising post-seed rounds. These are the best of the Midwest's recently-seeded ventures, developing innovations that can impact human healthcare. Main focus areas of the fund are digital therapeutics, diagnostics, medical devices/imaging, biotech tools, and water/chemistry technologies. 30Ventures' principals bring deep experience in commercializing innovation in these sectors and are committed to entrepreneurial success in the Midwest.